Pass the Medical Council of Canada MCCQE Part 1 MCCQE Questions and answers with Dumpstech

Comprehensive and Detailed Explanation:

Travel to rural Cambodia poses a high risk of malaria, which can be life-threatening in pregnancy. Antimalarial prophylaxis is strongly recommended for pregnant women traveling to endemic regions. Chloroquine or mefloquine (depending on resistance patterns) may be used in pregnancy under specialist guidance.

Toronto Notes 2023 – Infectious Disease / Travel Medicine:

“Malaria prophylaxis is indicated in pregnant women traveling to endemic regions. The risk of severe malaria and poor fetal outcomes is high.”

MCCQE1 Objectives (Public Health > 65-3: Travel Medicine and Pregnancy):

“Candidates must provide preventive care to pregnant travelers including vaccination and malaria prophylaxis.”

Tetanus boosters (D) are given every 10 years. Hep B Ig (B) is for acute post-exposure prophylaxis. Ciprofloxacin (C) is contraindicated in pregnancy.

Comprehensive and Detailed Explanation:

The levonorgestrel-releasing intrauterine device (LNG-IUD) is generally contraindicated in current or recent breast cancer due to the progestin component, but may be considered in select patients on tamoxifen, especially if non-hormonal options are unsuitable. Consultation with the oncologist is required to evaluate risks and benefits.

Toronto Notes 2023 – Gynecology, “Contraception in Special Populations”:

“Levonorgestrel IUDs are generally avoided in patients with a history of hormone-sensitive cancers; however, decisions should be made collaboratively with oncology.”

MCCQE1 Objectives (Gynecology > 82-2: Contraception):

“Candidates must tailor contraceptive advice to patients with medical comorbidities, including cancer survivors.”

Irregular bleeding (A) is a common but not contraindicating side effect. No pre-procedure antibiotics (D) are typically needed. The IUD does not cause infertility (E). Risk of recurrence (C) is unconfirmed and must be individualized.

—

For pregnant patients with opioid use disorder, opioid agonist therapy with methadone or buprenorphine is the standard of care. Detoxification is not recommended in pregnancy due to increased risk of fetal distress, preterm labor, and relapse. Methadone reduces illicit opioid use and stabilizes both mother and fetus.

Toronto Notes 2023 – Addiction Medicine / Obstetrics:

“Methadone maintenance therapy is the treatment of choice for pregnant patients with opioid use disorder. Detoxification is not advised during pregnancy due to relapse risk and potential harm to the fetus.”

MCCQE1 Objectives (Obstetrics > 80-3: Substance Use in Pregnancy):

“Candidates must manage opioid use disorder in pregnancy with evidence-based therapies, including referral for methadone or buprenorphine.”

Counselling alone (D) is insufficient as first-line therapy. Home detox (C) is unsafe. Inpatient detox (A) is not recommended in pregnancy.

====================================================

In cross-cultural care, especially for recent immigrants, it is essential to build rapport and respect patient preferences regarding family involvement. Involving family in the interview respects cultural norms and improves trust. A trained interpreter should be used to maintain confidentiality and accuracy, but collaboration with the family initially may encourage later private disclosure.

Toronto Notes 2023 – Ethics and Communication, “Cultural Competence”:

“When encountering language or cultural barriers, patient comfort and cultural context must be respected. Interviewing the patient and family together may facilitate trust, after which individual conversations may be possible.”

MCCQE1 Objectives (ELOM > 90-1: Communication and Patient-Centered Care):

“Candidates must approach patients in a culturally sensitive manner, particularly recent immigrants or those with language barriers, and foster trust.”

Insisting on a private interview (A) may alienate the patient. Family members should not act as interpreters (C). Written accounts (D) are inefficient and impersonal in acute mental health settings.

====================================================

Long-term opioid therapy requires ongoing assessment of benefits, risks, function, adverse effects, and safety, particularly in older adults. MCCQE objectives emphasize regular reassessment before making changes to chronic controlled medications. Although the pharmacist has appropriately raised concern about prolonged opioid use, the patient was reported one month ago to be functioning well without adverse effects.

The appropriate next step is to reassess the patient directly—including pain control, functional status, cognition, fall risk, constipation, signs of misuse, and overall goals of care—before altering therapy. Automatic dose reduction without evaluation may destabilize pain control. Immediate referral to a specialist is unnecessary if the patient is stable and well managed. Adjunct therapies such as physiotherapy may be considered but should not replace proper reassessment.

Shared decision-making is essential. If reassessment reveals limited benefit, adverse effects, or safety concerns, a gradual taper can then be discussed. Clinical decisions regarding opioids should be individualized rather than based solely on duration of use.

In Canada and other high-resource settings where safe alternatives are readily available, women living with HIV are advised to exclusively formula-feed their infants to eliminate the risk of postnatal HIV transmission through breast milk. HIV can be transmitted during pregnancy, delivery, and breastfeeding. While effective maternal combination antiretroviral therapy and neonatal prophylaxis significantly reduce perinatal transmission risk, breastfeeding still carries a residual risk because HIV is present in breast milk. Boiling expressed breast milk is not recommended as a standard preventive strategy in high-resource settings. Avoiding kissing is unnecessary, as casual contact does not transmit HIV. Breastfeeding only during the colostrum period does not eliminate transmission risk. According to MCCQE objectives, physicians must provide evidence-based counseling regarding prevention of vertical transmission, including maternal antiretroviral therapy, appropriate mode of delivery when indicated, neonatal prophylaxis, and avoidance of breastfeeding when safe formula feeding is accessible. Clear counseling supports informed decision-making and optimal neonatal outcomes.

In Canada, a minor may consent to medical care if the physician believes they have the capacity to understand the nature, benefits, and risks. This is known as the “mature minor doctrine.” Capacity is based on understanding, not age.

Toronto Notes 2023 – ELOM, “Consent and Capacity” Section:

“A minor may consent to treatment if they demonstrate sufficient maturity and understanding. It is the physician’s responsibility to assess capacity prior to prescribing.”

MCCQE1 Objectives (ELOM > 99-3: Consent and Confidentiality):

“Candidates must assess the patient’s ability to understand and make informed decisions, regardless of age.”

Prescribing without assessment (B) is premature. Reporting to child services (A) is only necessary if there are signs of abuse or coercion. Parental involvement (C) is not mandatory. Refusal based on age (E) contradicts legal and ethical practice.

====================================================

This scenario raises end-of-life ethics: balancing relief of suffering with the prohibition against intentionally hastening death. MCCQE ELOM objectives emphasize compassionate communication, capacity, consent, and appropriate use of palliative interventions. The immediate best step is to acknowledge the family’s distress, explore what they are witnessing (pain, dyspnea, agitation, delirium), and reassure them that you will continue to prioritize the patient’s comfort.

Options B and C are inappropriate because the family cannot authorize “expediting death,” and MAID requires a voluntary request from the patient with decision-making capacity (and other legal safeguards); a substitute decision-maker cannot request MAID on the patient’s behalf. Option D (midazolam for deep sedation) may be appropriate only if the patient has refractory symptoms despite optimal treatment and after careful assessment, consent discussions (with the patient if capable or SDM for goals-of-care), and proportional dosing aimed at symptom relief—not to cause death.

Therefore, the ethically correct next step is supportive, clarifying communication and reassessment of symptom control.

A fetus that is chronically growth-restricted and has persistently reduced fetal movement raises concern for an underlying fetal condition rather than isolated placental insufficiency. MCCQE objectives emphasize that early-onset or persistent fetal growth restriction , especially when accompanied by abnormal fetal behavior (notably reduced movement), is associated with higher rates of aneuploidy and other chromosomal disorders (e.g., trisomy syndromes), as well as congenital anomalies and neuromuscular disorders. Among the listed options, chromosomal abnormalities best fit the combined pattern of longstanding small size and consistently diminished movement.

Normal maternal serum screening reduces risk but does not eliminate it; screening tests can miss chromosomal abnormalities, and some aneuploidies may not be reliably detected depending on the test used and gestational timing. Spina bifida is more typically associated with elevated maternal serum AFP and structural findings on ultrasound. Fetal stroke is usually an acute event with more abrupt changes. Congenital hypothyroidism and infantile diabetes are not typical causes of markedly reduced fetal movement with chronic growth restriction.

Patients with developmental disabilities must still be engaged directly unless clearly incapable. It is vital to first establish the companion’s relationship to the patient and give the patient the opportunity to communicate.

Toronto Notes 2023 – ELOM, Consent and Capacity:

“Presume capacity in adults with developmental disabilities unless proven otherwise. Direct communication with the patient is essential, and the identity of accompanying individuals should be clarified.”

MCCQE1 Objectives – ELOM > Patient Autonomy and Consent:

“Candidates must respect patient autonomy and include developmentally delayed individuals in medical discussions unless incapacity is determined.”

Options A and C delay establishing capacity and relationship. Option D is premature. Option E bypasses consent and interaction with the patient.